
Epidemiological characteristics and access to end-stage liver disease care for HIV-positive patients with HCV and/or HBV coinfections in Central/Eastern European and neighboring countries – data from the ECEE network
Author(s) -
Agata SkrzatKlapaczyńska,
Bartłomiej Matłosz,
Dan Oțelea,
Arjan Harxhi,
Anna Vassilenko,
N Bolokadze,
Kristi Rüütel,
Αντωνιοσ Παπαδοπουλοσ,
Mariana Mărdărescu,
Mike Youle,
Justyns D. Kowalska,
A. Horban
Publication year - 2019
Publication title -
przegląd epidemiologiczny
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.158
H-Index - 18
eISSN - 2545-1898
pISSN - 0033-2100
DOI - 10.32394/pe.73.07
Subject(s) - coinfection , medicine , hepatitis c , liver disease , epidemiology , hepatitis b , liver transplantation , disease , human immunodeficiency virus (hiv) , immunology , transplantation
There is currently an urgent need to harmonize hepatitis standards of care for HIV-positive patients across Europe. The HIV epidemic in Central and Eastern Europe has often been driven by injecting drug use, therefore a higher rate of co-infection with HCV and HBV is expected in this region. We have investigated the epidemiological prevalence and treatment availability for end-stage liver disease in HIV/HCV/HBV coinfections in countries represented in the ECEE Network Group.